These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34036839)

  • 1. Spotlight on Adenovirus-Based Vaccines and Rare Thrombotic Events.
    Chirumbolo S
    Clin Appl Thromb Hemost; 2021; 27():10760296211020829. PubMed ID: 34036839
    [No Abstract]   [Full Text] [Related]  

  • 2. Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines.
    Kremer EJ
    Mol Ther; 2020 Nov; 28(11):2303-2304. PubMed ID: 33065038
    [No Abstract]   [Full Text] [Related]  

  • 3. Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19.
    Jolobe OMP
    Am J Emerg Med; 2022 Apr; 54():318-319. PubMed ID: 34059386
    [No Abstract]   [Full Text] [Related]  

  • 4. Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health.
    Ertl HCJ; Currie SL; Luber AD
    Front Immunol; 2022; 13():985382. PubMed ID: 36091063
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of adenovirus type-5 vector vaccines in COVID-19: potential implications for metabolic health?
    Tsilingiris D; Vallianou NG; Karampela I; Muscogiuri G; Dalamaga M
    Minerva Endocrinol (Torino); 2022 Sep; 47(3):264-269. PubMed ID: 35621112
    [No Abstract]   [Full Text] [Related]  

  • 6. Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
    Rubin EJ; Baden LR; Walensky RP; Morrissey S
    N Engl J Med; 2021 Apr; 384(16):e73. PubMed ID: 33882211
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?].
    Hardy M; Douxfils J; Dogné JM; Lessire S; Chatelain B; Testa S; Gouin-Thibault I; Gruel Y; Lecompte T; Mullier F
    Ann Biol Clin (Paris); 2020 Oct; 78(5):471-481. PubMed ID: 33026344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic analysis of suspected COVID-19 patients in a SARS-CoV-2 non-epidemic area of China.
    Ji YH; Qi T; Ding Y; Ruan Q; Ma YP
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9196-9201. PubMed ID: 32965014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Vaccines.
    Creech CB; Walker SC; Samuels RJ
    JAMA; 2021 Apr; 325(13):1318-1320. PubMed ID: 33635317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Coagulopathies, thrombotic risk and anticoagulation in COVID-19].
    Peters P; Sprynger M; Lancellotti P; Oury C
    Rev Med Liege; 2020 Sup; 75(S1):86-93. PubMed ID: 33211428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Pottie K; Hin ANC; Saad A
    Can Fam Physician; 2022 Jun; 68(6):434-437. PubMed ID: 35701204
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19.
    Bemtgen X; Zotzmann V; Benk C; Rilinger J; Steiner K; Asmussen A; Bode C; Wengenmayer T; Maier S; Staudacher DL
    J Thromb Thrombolysis; 2021 Feb; 51(2):301-307. PubMed ID: 32653986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.
    Memar Montazerin S; Najafi H; Shojaei F; Chi G; Goudarzi S; Sharfaei S; Kahe F; Hassanzadeh S
    Infez Med; 2021 Mar; 29(1):1-9. PubMed ID: 33664168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors.
    Kreppel F; Hagedorn C
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origin of severe hepatitis of unknown aetiology in children: SARS-CoV-2 or adenovirus?
    Yi H; Lin Y; Lu B; Mao Y
    J Hepatol; 2023 Jan; 78(1):e16-e18. PubMed ID: 36067884
    [No Abstract]   [Full Text] [Related]  

  • 17. Arterial thrombotic complications in hospitalized patients with COVID-19. Response to related letters.
    Rey JR; Merino JL; Iniesta ÁM; Caro-Codón J;
    Rev Esp Cardiol (Engl Ed); 2021 Jan; 74(1):116. PubMed ID: 33121911
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing a SARS-CoV-2 Vaccine at Warp Speed.
    O'Callaghan KP; Blatz AM; Offit PA
    JAMA; 2020 Aug; 324(5):437-438. PubMed ID: 32628244
    [No Abstract]   [Full Text] [Related]  

  • 19. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers.
    Song JY; Cheong HJ; Kim SR; Lee SE; Kim SH; Noh JY; Yoon YK; Choi WS; Park DW; Sohn JW; Kim WJ; Kim MJ
    J Korean Med Sci; 2021 Apr; 36(15):e110. PubMed ID: 33876589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation Dysfunction.
    Fei Y; Tang N; Liu H; Cao W
    Arch Pathol Lab Med; 2020 Oct; 144(10):1223-1229. PubMed ID: 32551814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.